NO20012214D0 - Fremstilling av en biologisk faktor og frembringelse av et immunologisk fordelaktig miljö ved anvendelse av genetiskforandrede Sertoliceller - Google Patents
Fremstilling av en biologisk faktor og frembringelse av et immunologisk fordelaktig miljö ved anvendelse av genetiskforandrede SertolicellerInfo
- Publication number
- NO20012214D0 NO20012214D0 NO20012214A NO20012214A NO20012214D0 NO 20012214 D0 NO20012214 D0 NO 20012214D0 NO 20012214 A NO20012214 A NO 20012214A NO 20012214 A NO20012214 A NO 20012214A NO 20012214 D0 NO20012214 D0 NO 20012214D0
- Authority
- NO
- Norway
- Prior art keywords
- sertoli cells
- biological factor
- creation
- preparation
- genetically modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10743898P | 1998-11-06 | 1998-11-06 | |
PCT/US1999/026072 WO2000027409A1 (en) | 1998-11-06 | 1999-11-04 | Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012214D0 true NO20012214D0 (no) | 2001-05-04 |
NO20012214L NO20012214L (no) | 2001-07-06 |
Family
ID=22316637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012214A NO20012214L (no) | 1998-11-06 | 2001-05-04 | Fremstilling av en biologisk faktor og frembringelse av et immunologisk fordelaktig miljö ved anvendelse av genetiskforandrede Sertoliceller |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1126858B1 (no) |
JP (1) | JP5323293B2 (no) |
AT (1) | ATE452643T1 (no) |
AU (1) | AU767763B2 (no) |
CA (1) | CA2349475C (no) |
DE (1) | DE69941849D1 (no) |
DK (1) | DK1126858T3 (no) |
ES (1) | ES2338076T3 (no) |
NO (1) | NO20012214L (no) |
WO (1) | WO2000027409A1 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60128130T2 (de) * | 2000-11-03 | 2007-12-27 | Zymogenetics, Inc., Seattle | Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a |
US20040014657A1 (en) * | 2001-11-05 | 2004-01-22 | Jan Ohrstrom | Use of blood coagulation factor XIII for treating haemophilia A |
EP2046351A2 (en) * | 2006-07-28 | 2009-04-15 | Sertocell Biotechnology (US) Corp. | Adult sertoli cells and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09512015A (ja) * | 1994-04-13 | 1997-12-02 | リサーチ・コーポレイション・テクノロジーズ・インコーポレイテッド | セルトーリ細胞および同種移植片または異種移植片を用いる疾患処置方法 |
US5702700A (en) * | 1995-03-13 | 1997-12-30 | University Of South Florida | Sertoli cells as neurorecovery inducing cells for Parkinson's disease |
-
1999
- 1999-11-04 CA CA002349475A patent/CA2349475C/en not_active Expired - Fee Related
- 1999-11-04 ES ES99961585T patent/ES2338076T3/es not_active Expired - Lifetime
- 1999-11-04 WO PCT/US1999/026072 patent/WO2000027409A1/en active IP Right Grant
- 1999-11-04 DE DE69941849T patent/DE69941849D1/de not_active Expired - Lifetime
- 1999-11-04 DK DK99961585.9T patent/DK1126858T3/da active
- 1999-11-04 AT AT99961585T patent/ATE452643T1/de not_active IP Right Cessation
- 1999-11-04 EP EP99961585A patent/EP1126858B1/en not_active Expired - Lifetime
- 1999-11-04 AU AU18132/00A patent/AU767763B2/en not_active Ceased
- 1999-11-04 JP JP2000580638A patent/JP5323293B2/ja not_active Expired - Fee Related
-
2001
- 2001-05-04 NO NO20012214A patent/NO20012214L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE452643T1 (de) | 2010-01-15 |
DK1126858T3 (da) | 2010-03-01 |
AU767763B2 (en) | 2003-11-20 |
EP1126858B1 (en) | 2009-12-23 |
DE69941849D1 (de) | 2010-02-04 |
CA2349475C (en) | 2010-01-05 |
ES2338076T3 (es) | 2010-05-03 |
WO2000027409A1 (en) | 2000-05-18 |
JP2002529419A (ja) | 2002-09-10 |
EP1126858A4 (en) | 2004-06-30 |
EP1126858A1 (en) | 2001-08-29 |
JP5323293B2 (ja) | 2013-10-23 |
NO20012214L (no) | 2001-07-06 |
CA2349475A1 (en) | 2000-05-18 |
AU1813200A (en) | 2000-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0702563T3 (da) | Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme | |
DK0559884T3 (da) | Rekombinante virusvektorer til ekspression i muskelceller | |
DE69525151D1 (de) | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat | |
PL322015A1 (en) | Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them | |
AU6331898A (en) | Forskohlin for promoting lean body mass | |
DE69518910T2 (de) | Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle | |
ATE526818T1 (de) | Gentechnisch hergestellte wasserlinse | |
BR9712556A (pt) | Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno | |
PT851926E (pt) | Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada | |
DE69637709D1 (de) | Durch elektroporation vermittelter molekulartransfer in intakten pflanzen | |
BR9707994A (pt) | Adenovírus recombinantes defectivo composição farmacêutica utilização do adenovirus composição e processo de preparação de células t citotóxicas especificas de um antigene tumoral | |
NO20012214L (no) | Fremstilling av en biologisk faktor og frembringelse av et immunologisk fordelaktig miljö ved anvendelse av genetiskforandrede Sertoliceller | |
EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
ATE233321T1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
EP2281892A3 (en) | Methods for producing polypeptides in respiratory-deficient Trichoderma cells | |
EP0684831A4 (en) | ALLOGENIC VACCINE AND METHOD FOR SYNTHESIZING THE SAME. | |
BG101125A (en) | Low molecular biologically active substance of yeasts and method for its preparation | |
PL363501A1 (en) | Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity | |
DE69920216D1 (de) | Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren | |
DK0966532T3 (da) | Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette | |
ATE508771T1 (de) | Zytoprotektion durch phosphotyrosin | |
JPS5568287A (en) | Method of cultivating crown gall tissue of nicotiana plant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |